Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.
暂无分享,去创建一个
[1] A. Quyyumi,et al. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. , 1998, Circulation.
[2] A. Quyyumi,et al. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. , 1998, Hypertension.
[3] A. Quyyumi,et al. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. , 1997, Journal of the American College of Cardiology.
[4] A. M. Lefer,et al. Regulation of P-selectin expression in human endothelial cells by nitric oxide. , 1997, The American journal of physiology.
[5] A. Quyyumi,et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.
[6] A. Quyyumi,et al. Nitric oxide activity in the atherosclerotic human coronary circulation. , 1997, Journal of the American College of Cardiology.
[7] P. Ganz,et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. , 1997, Circulation.
[8] A. Quyyumi,et al. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. , 1997, Circulation.
[9] J. Stamler,et al. Biological chemistry of thiols in the vasculature and in vascular-related disease. , 2009, Nutrition reviews.
[10] J. Ferguson,et al. American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996. , 1996, Circulation.
[11] R. Cannon,et al. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. , 1996, Circulation.
[12] A. Yeung,et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. , 1996, Circulation.
[13] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[14] A. Keech,et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. , 1996, The Journal of clinical investigation.
[15] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[16] G. Levine,et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.
[17] D. Harrison,et al. REGULATION OF EXPRESSION OF THE ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE , 1996, Clinical and experimental pharmacology & physiology.
[18] A. Quyyumi,et al. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. , 1995, Hypertension.
[19] A. Quyyumi,et al. Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. , 1995, The American journal of cardiology.
[20] V. Schini-Kerth,et al. Nitric oxide synthases in vascular cells , 1995, Experimental physiology.
[21] A. Yeung,et al. Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.
[22] A. Quyyumi,et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1995, Circulation.
[23] R. Busse,et al. Regulation and functional consequences of endothelial nitric oxide formation. , 1995, Annals of medicine.
[24] D. Harrison,et al. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. , 1995, The Journal of clinical investigation.
[25] A. Quyyumi,et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.
[26] A. Quyyumi,et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. , 1995, Circulation.
[27] A. Yeung,et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.
[28] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[29] A. Quyyumi,et al. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. , 1995, The American journal of cardiology.
[30] P. Ganz,et al. Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women , 1994, Annals of Internal Medicine.
[31] A. Quyyumi,et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. , 1994, Journal of the American College of Cardiology.
[32] M. Sugimachi,et al. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. , 1994, Journal of the American College of Cardiology.
[33] J. Witztum,et al. The oxidation hypothesis of atherosclerosis , 1994, The Lancet.
[34] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.
[35] A. Quyyumi,et al. Acute Vascular Effects of Estrogen in Postmenopausal Women , 1994, Circulation.
[36] A. Quyyumi,et al. Selective Loss of Microvascular Endothelial Function in Human Hypercholesterolemia , 1994, Circulation.
[37] A. Quyyumi,et al. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.
[38] S. Moncada,et al. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. , 1994, Cardiovascular research.
[39] A. Quyyumi,et al. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. , 1994, Journal of the American College of Cardiology.
[40] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[41] A. Quyyumi,et al. Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension , 1993, Circulation.
[42] A. Quyyumi,et al. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. , 1993, Journal of the American College of Cardiology.
[43] J. Stamler,et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.
[44] G. Rubanyi,et al. The role of endothelium in cardiovascular homeostasis and diseases. , 1993, Journal of cardiovascular pharmacology.
[45] M. Sugimachi,et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[46] A. Quyyumi,et al. Endothelial Dysfunction in Patients With Chest Pain and Normal Coronary Arteries , 1992, Circulation.
[47] A. Castaigne,et al. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. , 1992, The American journal of cardiology.
[48] J. Cooke,et al. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.
[49] K. Bhoola,et al. Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.
[50] H. Drexler,et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.
[51] A. Yeung,et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.
[52] J. Sasaki,et al. Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Drexler,et al. Endothelial Dysfunction of the Coronary Microvasculature Is Associated With Impaired Coronary Blood Flow Regulation in Patients With Early Atherosclerosis , 1991, Circulation.
[54] P. Kerth,et al. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. , 1991, American journal of hypertension.
[55] J. Cooke,et al. Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta , 1991, Circulation.
[56] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[57] E. Werner,et al. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts , 1990, The Journal of experimental medicine.
[58] V Ionescu,et al. [Silent myocardial ischemia]. , 1990, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna.
[59] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.
[60] H. Drexler,et al. Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.
[61] Z. Katušić,et al. Superoxide anion is an endothelium-derived contracting factor. , 1989, The American journal of physiology.
[62] R. Fish,et al. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. , 1988, Circulation.
[63] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[64] P. Vanhoutte,et al. Endothelium‐dependent hyperpolarization of canine coronary smooth muscle , 1988, British journal of pharmacology.
[65] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[66] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[67] V. Miller,et al. Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase. , 1985, The American journal of physiology.
[68] U. Förstermann,et al. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. , 1984, Journal of cardiovascular pharmacology.
[69] U. Förstermann,et al. The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. , 1984, European journal of pharmacology.
[70] E. Antman,et al. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.
[71] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.